Targeting CREB for cancer therapy: Friend or foe

Current Cancer Drug Targets

Volumn 10, Issue 4, 2010, Pages 384-391

  Xiao, X ^a   Li, B X ^a   Mitton, B ^b   Ikeda, A ^b   Sakamoto, K M ^b,c,d  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b MATTEL CHILDREN S HOSPITAL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cancer; CBP; CREB; Inhibitors; KID; KIX; Naphthol AS E; Ro 31 8220

Indexed keywords

2 [1 (3 AMIDINOTHIOPROPYL) 1H INDOL 3 YL] 3 (1 METHYL 1H INDOL 3 YL)MALEIMIDE; ANTINEOPLASTIC AGENT; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DNA; NSC 12155; NSC 45576; NSC12155; NSC45576; UNCLASSIFIED DRUG; VASCULOTROPIN;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER THERAPY; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; DRUG ACTIVITY; DRUG INHIBITION; DRUG MECHANISM; DRUG STRUCTURE; GENETIC TRANSCRIPTION; HUMAN; METASTASIS; NONHUMAN; ONCOGENE; PROSTATE CANCER; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING;

ANIMALS; CELL LINE, TUMOR; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASMS; PHOSPHORYLATION;

EID: 77953662351     PISSN: 15680096     EISSN: None     Source Type: Journal    
DOI: 10.2174/156800910791208535     Document Type: Article

References (75)

1. Montminy, M. R.; Bilezikjian, L. M. Binding of a nuclear-protein to the cyclic-AMP response element of the somatostatin gene. Nature 1987, 328, 175-178.
2. Montminy, M. R.; Sevarino, K. A.; Wagner, J. A.; Mandel, G.; Goodman, R. H. Identification of a cyclic-AMP-responsive element within the rat somatostatin gene. Proc. Natl. Acad. Sci. USA 1986, 83, 6682-6686.
3. Vinson, C. R.; Sigler, P. B.; McKnight, S. L. Scissors-grip model for DNA recognition by a family of leucine zipper proteins. Science 1989, 246, 911-916.
4. Shaywitz, A. J.; Greenberg, M. E. CREB: A stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu. Rev. Biochem. 1999, 68, 821-861.
5. Du, K. Y.; Montminy, M. CREB is a regulatory target for the protein kinase Akt/PKB. J. Biol. Chem. 1998, 273, 32377-32379.
6. Tan, Y.; Rouse, J.; Zhang, A. H.; Cariati, S.; Cohen, P.; Comb, M. J. FGF and stress regulate CREB and ATF-1 via a pathway involving p38 MAP kinase and MAPKAP kinase-2. EMBO J. 1996, 15, 4629-4642.
7. Ginty, D. D.; Bonni, A.; Greenberg, M. E. Nerve growth factor activates a Ras-dependent protein kinase that stimulates c-fos transcription via phosphorylation of CREB. Cell 1994, 77, 713-725.
8. Xing, J.; Ginty, D. D.; Greenberg, M. E. Coupling of the RAS- MAPK pathway to gene activation by RSK2, a growth factor- regulated CREB kinase. Science 1996, 273, 959-963.
9. Radhakrishnan, I.; PerezAlvarado, G. C.; Parker, D.; Dyson, H. J.; Montminy, M. R.; Wright, P. E. Solution structure of the KIX domain of CBP bound to the transactivation domain of CREB: A model for activator:Coactivator interactions. Cell 1997, 91, 741-752.
10. Johannessen, M.; Moens, U. Multisite phosphorylation of the cAMP response element-binding protein (CREB) by a diversity of protein kinases. Front. Biosci. 2007, 12, 1814-1832.
11. Mayr, B.; Montminy, M. Transcriptional regulation by the phos-phorylation-dependent factor CREB. Nat. Rev. Mol. Cell Biol. 2001, 2, 599-609.
12. Conkright, M. D.; Montminy, M. CREB: the unindicted cancer co-conspirator. Trends Cell Biol. 2005, 15, 457-459.
13. Sakamoto, K. M.; Frank, D. A. CREB in the pathophysiology of cancer: implications for targeting transcription factors for cancer therapy. Clin. Cancer Res. 2009, 15, 2583-2587.
14. Sandoval, S.; Pigazzi, M.; Sakamoto, K. M. CREB: A Key Regulator of Normal and Neoplastic Hematopoiesis. Adv. Hematol. 2009, 2009, 634292.
15. Zucman, J.; Delattre, O.; Desmaze, C.; Epstein, A. L.; Stenman, G.; Speleman, F.; Fletchers, C. D. M.; Aurias, A.; Thomas, G. EWS and ATF-1 gene fusion induced by T(12,22) translocation in malignant melanoma of soft parts. Nat. Genet. 1993, 4, 341-345.
16. Delattre, O.; Zucman, J.; Plougastel, B.; Desmaze, C.; Melot, T.; Peter, M.; Kovar, H.; Joubert, I.; Dejong, P.; Rouleau, G.; Aurias, A.; Thomas, G. Gene fusion with an ETS DNA-binding domain caused by chromosone-translocation in human tumors. Nature 1992, 359, 162-165.
17. Hai, T. W.; Liu, F.; Coukos, W. J.; Green, M. R. Transcription factor ATF cDNA clones--an extensive family of leucine zipper proteins able to selectively form cDNA-binding heterodimers. Genes Dev. 1989, 3, 2083-2090.
18. Schaefer, K. L.; Brachwitz, K.; Wai, D. H.; Braun, Y.; Diallo, R.; Korsching, E.; Eisenacher, M.; Voss, R.; van Valen, F.; Baer, C.; Selle, B.; Spahn, L.; Liao, S. K.; Lee, K. A. W.; Hogendoorn, P. C. W.; Reifenberger, G.; Gabbert, H. E.; Poremba, C. Expression profiling of t(12;22) positive clear cell sarcoma of soft tissue cell lines reveals characteristic up-regulation of potential new marker genes including ERBB3. Cancer Res. 2004, 64, 3395-3405.
19. Fujimura, Y.; Ohno, T.; Siddique, H.; Lee, L.; Rao, V. N.; Reddy, E. S. P. The EWS-ATF-1 gene involved in malignant melanoma of soft parts with t(12;22) chromosome translocation, encodes a constitutive transcriptional activator. Oncogene 1996, 12, 159-167.
20. Wu, W.; Zhau, H. E.; Huang, W. C.; Iqbal, S.; Habib, F. K.; Sartor, O.; Cvitanovic, L.; Marshall, F. F.; Xu, Z.; Chung, L. W. K. cAMP-responsive element-binding protein regulates vascular endo-thelial growth factor expression: implication in human prostate cancer bone metastasis. Oncogene 2007, 26, 5070-5077.
21. Deng, X.; Liu, H.; Huang, J.; Cheng, L.; Keller, E. T.; Parsons, S. J.; Hu, C. D. Ionizing radiation induces prostate cancer neuroendo-crine differentiation through interplay of CREB and ATF2: implications for disease progression. Cancer Res. 2008, 68, 9663-9670.
22. Bang, Y. J.; Pirnia, F.; Fang, W. G.; Kang, W. K.; Sartor, O.; Whitesell, L.; Ha, M. J.; Tsokos, M.; Sheahan, M. D.; Nguyen, P.; Niklinski, W. T.; Myers, C. E.; Trepel, J. B. Terminal neuroendo-crine differentiation of human prostate carcinoma cells in response to increased intracellular cyclic AMP. Proc. Natl. Acad. Sci. USA 1994, 91, 5330-5334.
23. Yuan, T. C.; Veeramani, S.; Lin, M. F. Neuroendocrine-like prostate cancer cells: neuroendocrine transdifferentiation of prostate adenocarcinoma cells. Endocr. Relat. Cancer 2007, 14, 531-547.
24. Deeble, P. D.; Cox, M. E.; Frierson, H. F., Jr.; Sikes, R. A.; Palmer, J. B.; Davidson, R. J.; Casarez, E. V.; Amorino, G. P.; Parsons, S. J. Androgen-independent growth and tumorigenesis of prostate cancer cells are enhanced by the presence of PKA-differentiated neuroendocrine cells. Cancer Res. 2007, 67, 3663-3672.
25. Chhabra, A.; Fernando, H.; Watkins, G.; Mansel, R. E.; Jiang, W. G. Expression of transcription factor CREB1 in human breast cancer and its correlation with prognosis. Oncol. Rep. 2007, 18, 953-958.
26. Seo, H.S.; Liu, D. D.; Bekele, B. N.; Kim, M. K.; Pisters, K.; Lippman, S. M.; Wistuba, II.; Koo, J. S. Cyclic AMP response element-binding protein overexpression: A feature associated with negative prognosis in never smokers with non-small cell lung cancer. Cancer Res. 2008, 68, 6065-6073.
27. Cekanova, M.; Majidy, M.; Masi, T.; Al-Wadei, H. A.; Schuller, H. M. Overexpressed Raf-1 and phosphorylated cyclic adenosine 3'-5'-monophosphatate response element-binding protein are early markers for lung adenocarcinoma. Cancer 2007, 109, 1164-1173.
28. Laag, E.; Majidi, M.; Cekanova, M.; Masi, T.; Takahashi, T.; Schuller, H. M. NNK activates ERK1/2 and CREB/ATF-1 via beta-1-AR and EGFR signaling in human lung adenocarcinoma and small airway epithelial cells. Int. J. Cancer 2006, 119, 1547-1552.
29. Yoshida, M.; Seiki, M.; Yamaguchi, K.; Takatsuki, K. Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia-virus in the disease. Proc. Natl. Acad. Sci. USA 1984, 81, 2534-2537.
30. Poiesz, B. J.; Ruscetti, F. W.; Gazdar, A. F.; Bunn, P. A.; Minna, J. D.; Gallo, R. C. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc. Natl. Acad. Sci. USA 1980, 77, 7415-7419.
31. Akagi, T.; Ono, H.; Nyunoya, H.; Shimotohno, K. Characterization of peripheral blood T-lymphocytes transduced with HTLV-I Tax mutants with different trans-activating phenotypes. Oncogene 1997, 14, 2071-2078.
32. Smith, M. R.; Greene, W. C. Type-I human T-cell leukemia-virus Tax protein transforms rat fibroblasts through the cyclic adenosine-monophosphate response element binding-protein/activating transcription factor pathway. J. Clin. Invest. 1991, 88, 1038-1042.
33. Shankar, D. B.; Cheng, J. C.; Kinjo, K.; Federman, N.; Moore, T. B.; Gill, A.; Rao, N. P.; Landaw, E. M.; Sakamoto, K. M. The role of CREB as a proto-oncogene in hematopoiesis and in acute myeloid leukemia. Cancer Cell 2005, 7, 351-362.
34. Kinjo, K.; Sandoval, S.; Sakamoto, K. M.; Shankar, D. B. The role of CREB as a proto-oncogene in hematopoiesis. Cell Cycle 2005, 4, 1134-1135.
35. Crans-Vargas, H. N.; Landaw, E. M.; Bhatia, S.; Sandusky, G.; Moore, T. B.; Sakamoto, K. M. Expression of cyclic adenosine monophosphate response-element binding protein in acute leukemia. Blood 2002, 99, 2617-2619.
36. Pigazzi, M.; Ricotti, E.; Germano, G.; Faggian, D.; Arico, M.; Basso, G. cAMP response element binding protein (CREB) over-expression CREB has been described as critical for leukemia progression. Haematologica 2007, 92, 1435-1437.
37. Pigazzi, M.; Manara, E.; Baron, E.; Basso, G. miR-34b targets cyclic AMP-responsive element binding protein in acute myeloid leukemia. Cancer Res. 2009, 69, 2471-2478.
38. Kumar, A. P.; Bhaskaran, S.; Ganapathy, M.; Crosby, K.; Davis, M. D.; Kochunov, P.; Schoolfield, J.; Yeh, I. T.; Troyer, D. A.; Ghosh, R. Akt/cAMP-responsive element binding protein/cyclin D1 network: A novel target for prostate cancer inhibition in trans-genic adenocarcinoma of mouse prostate model mediated by Nexrutine, a Phellodendron amurense bark extract. Clin. Cancer Res. 2007, 13, 2784-2794.
39. Xie, S. H.; Price, J. E.; Luca, M.; Jean, D.; Ronai, Z.; BarEli, M. Dominant-negative CREB inhibits tumor growth and metastasis of human melanoma cells. Oncogene 1997, 15, 2069-2075.
40. Abramovich, C.; Pineault, N.; Ohta, H.; Humphries, R. K. Hox genes: from leukemia to hematopoietic stem cell expansion. Ann. N. Y. Acad. Sci. 2005, 1044, 109-116.
41. Esparza, S. D.; Chang, J.; Shankar, D. B.; Zhang, B.; Nelson, S. F.; Sakamoto, K. M. CREB regulates Meis1 expression in normal and malignant hematopoietic cells. Leukemia 2008, 22, 665-667.
42. Schumacher, M. A.; Goodman, R. H.; Brennan, R. G. The structure of a CREB bZIP.somatostatin CRE complex reveals the basis for selective dimerization and divalent cation-enhanced DNA binding. J. Biol. Chem. 2000, 275, 35242-35247.
43. Walton, K. M.; Rehfuss, R. P.; Chrivia, J. C.; Lochner, J. E.; Goodman, R. H. A dominant repessor of cyclic adenosin-3',5'-monphosphate (cAMP)-regulated enhancer-binding protein activity inhibits the cAMP-mediated induction of the somatostatin promoter in vivo. Mol. Endocrinol. 1992, 6, 647-655.
44. Yang, Y. M.; Dolan, L. R.; Ronai, Z. Expression of dominant negative CREB reduces resistance to radiation of human melanoma cells. Oncogene 1996, 12, 2223-2233.
45. Abramovitch, R.; Tavor, E.; Jacob-Hirsch, J.; Zeira, E.; Amariglio, N.; Pappo, O.; Rechavi, G.; Galun, E.; Honigman, A. A pivotal role of cyclic AMP-responsive element binding protein in tumor progression. Cancer Res. 2004, 64, 1338-1346.
46. Linnerth, N. M.; Baldwin, M.; Campbell, C.; Brown, M.; McGowan, H.; Moorehead, R. A. IGF-II induces CREB phos-phorylation and cell survival in human lung cancer cells. Oncogene 2005, 24, 7310-7319.
47. Rozenberg, J.; Rishi, V.; Orosz, A.; Moitra, J.; Glick, A.; Vinson, C. Inhibition of CREB function in mouse epidermis reduces papil-loma formation. Mol. Cancer Res. 2009, 7, 654-664.
48. Cho, Y. S.; Kim, M. K.; Cheadle, C.; Neary, C.; Park, Y. G.; Becker, K. G.; Cho-Chung, Y. S. A genomic-scale view of the cAMP response element-enhancer decoy: A tumor target-based genetic tool. Proc. Natl. Acad. Sci. USA 2002, 99, 15626-15631.
49. Park, Y. G.; Nesterova, M.; Agrawal, S.; Cho-Chung, Y. S. Dual blockade of cyclic AMP response element- (CRE) and AP-1-directed transcription by CRE-transcription factor decoy oligonu-cleotide - Gene-specific inhibition of tumor growth. J. Biol. Chem. 1999, 274, 1573-1580.
50. Cheng, J. C.; Kinjo, K.; Judelson, D. R.; Chang, J.; Wu, W. S.; Schmid, I.; Shankar, D. B.; Kasahara, N.; Stripecke, R.; Bhatia, R.; Landaw, E. M.; Sakamoto, K. M. CREB is a critical regulator of normal hematopoiesis and leukemogenesis. Blood 2008, 111, 1182-1192.
51. Barlow, C. A.; Kitiphongspattana, K.; Siddiqui, N.; Roe, M. W.; Mossman, B. T.; Lounsbury, K. M. Protein kinase A-mediated CREB phosphorylation is an oxidant-induced survival pathway in alveolar type II cells. Apoptosis 2008, 13, 681-692.
52. Shukla, A.; Bosenberg, M. W.; MacPherson, M. B.; Butnor, K. J.; Heintz, N. H.; Pass, H. I.; Carbone, M.; Testa, J. R.; Mossman, B. T. Activated cAMP response element binding protein is overex-pressed in human mesotheliomas and inhibits apoptosis. Am. J. Pathol. 2009, 175, 2197-2206.
53. Verma, I. M.; Somia, N. Gene therapy - promises, problems and prospects. Nature 1997, 389, 239-242.
54. Bilanges, B.; Torbett, N.; Vanhaesebroeck, B. Killing two kinase families with one stone. Nat. Chem. Biol. 2008, 4, 648-649.
55. Davis, P. D.; Hill, C. H.; Keech, E.; Lawton, G.; Nixon, J. S.; Sedgwick, A. D.; Wadsworth, J.; Westmacott, D.; Wilkinson, S.E. Potent selective inhibitors of protein kinase C. FEBS Lett. 1989, 259, 61-63.
56. Aggarwal, S.; Kim, S. W.; Ryu, S. H.; Chung, W. C.; Koo, J. S. Growth suppression of lung cancer cells by targeting cyclic AMP response element-binding protein. Cancer Res. 2008, 68, 981-988.
57. Rishi, V.; Potter, T.; Laudeman, J.; Reinhart, R.; Silvers, T.; Selby, M.; Stevenson, T.; Krosky, P.; Stephen, A. G.; Acharya, A.; Moll, J.; Oh, W. J.; Scudiero, D.; Shoemaker, R. H.; Vinson, C. A high-throughput fluorescence-anisotropy screen that identifies small molecule inhibitors of the DNA binding of B-ZIP transcription factors. Anal. Biochem. 2005, 340, 259-271.
58. Best, J. L.; Amezcua, C. A.; Mayr, B.; Flechner, L.; Murawsky, C. M.; Emerson, B.; Zor, T.; Gardner, K. H.; Montminy, M. Identification of small-molecule antagonists that inhibit an activator: coactivator interaction. Proc. Natl. Acad. Sci. USA 2004, 101, 17622-17627.
59. Li, B. X.; Xiao, X. Discovery of a Small-Molecule Inhibitor of the KIX-KID Interaction. Chem. Bio. Chem. 2009, 10, 2721-2724.
60. Wemmer, D. E.; Dervan, P. B. Targeting the minor groove of DNA. Curr. Opin. Struct. Biol. 1997, 7, 355-361.
61. Nickols, N. G.; Dervan, P. B. Suppression of androgen receptor-mediated gene expression by a sequence-specific DNA-binding polyamide. Proc. Natl. Acad. Sci. USA 2007, 104, 10418-10423.
62. Olenyuk, B. Z.; Zhang, G. J.; Klco, J. M.; Nickols, N. G.; Kaelin, W. G., Jr.; Dervan, P. B. Inhibition of vascular endothelial growth factor with a sequence-specific hypoxia response element antagonist. Proc. Natl. Acad. Sci. USA 2004, 101, 16768-16773.
63. Cardinaux, J. R.; Notis, J. C.; Zhang, Q.; Vo, N.; Craig, J. C.; Fass, D. M.; Brennan, R. G.; Goodman, R. H. Recruitment of CREB binding protein is sufficient for CREB-mediated gene activation. Mol. Cell. Biol. 2000, 20, 1546-1552.
64. Wells, J. A.; McClendon, C. L. Reaching for high-hanging fruit in drug discovery at protein-protein interfaces. Nature 2007, 450, 1001-1009.
65. De Guzman, R. N.; Goto, N. K.; Dyson, H. J.; Wright, P. E. Structural basis for cooperative transcription factor binding to the CBP coactivator. J. Mol. Biol. 2006, 355, 1005-1013.
66. Goto, N. K.; Zor, T.; Martinez-Yamout, M.; Dyson, H. J.; Wright, P. E. Cooperativity in transcription factor binding to the coactivator CREB-binding protein (CBP). The mixed lineage leukemia protein (MLL) activation domain binds to an allosteric site on the KIX domain. J. Biol. Chem. 2002, 277, 43168-43174.
67. Buhrlage, S. J.; Bates, C. A.; Rowe, S. P.; Minter, A. R.; Brennan, B. B.; Majmudar, C. Y.; Wemmer, D. E.; Al-Hashimi, H.; Mapp, A. K. Amphipathic small molecules mimic the binding mode and function of endogenous transcription factors. ACS Chem. Biol. 2009, 4, 335-344.
68. Xiao, X.; Yu, P.; Lim, H. S.; Sikder, D.; Kodadek, T. Design and synthesis of a cell-permeable synthetic transcription factor mimic. J. Comb. Chem. 2007, 9, 592-600.
69. Xiao, X.; Yu, P.; Lim, H. S.; Sikder, D.; Kodadek, T. A cell-permeable synthetic transcription factor mimic. Angew. Chem. Int. Ed. 2007, 46, 2865-2868.
70. Ruppert, S.; Cole, T. J.; Boshart, M.; Schmid, E.; Schutz, G. Multiple mRNA isoforms of the transcription activator protein CREB: generation by alternative splicing and specific expression in primary spermatocytes. EMBO J. 1992, 11, 1503-1512.
71. Rudolph, D.; Tafuri, A.; Gass, P.; Hammerling, G. J.; Arnold, B.; Schutz, G. Impaired fet-aletal/et-al T cell development and perinatal lethality in mice lacking the cAMP response element binding protein. Proc. Natl. Acad. Sci. USA 1998, 95, 4481-4486.
72. Evan, G. I.; Vousden, K. H. Proliferation, cell cycle and apoptosis in cancer. Nature 2001, 411, 342-348.
73. Hanahan, D.; Weinberg, R. A. The hallmarks of cancer. Cell, 2000, 100, 57-70.
74. Hummler, E.; Cole, T. J.; Blendy, J. A.; Ganss, R.; Aguzzi, A.; Schmid, W.; Beermann, F.; Schutz, G. Targeted mutation of the CREB gene: compensation within the CREB/ATF family of transcription factors. Proc. Natl. Acad. Sci. USA 1994, 91, 5647-5651.
75. Bulun, S. E.; Lin, Z.; Zhao, H.; Lu, M.; Amin, S.; Reierstad, S.; Chen, D. Regulation of aromatase expression in breast cancer tissue. Ann. N. Y. Acad. Sci. 2009, 1155, 121-131.